Cancer Family
Breast Neoplasm
CI-CAN-00000007Explore in graph →
Non-malignant2,895 active trials43 approved drugs310 evidence items
- NCIt
- C2910
- OncoTree
- BNNOS
- MeSH
- D000069584
- MeSH
- D001943
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000007Explore in graph →
Clinical trials
13,871 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT02961790 | Oxybutynin Chloride in Managing Hot Flashes | completed | Phase 3 | 150 | Academic and Community Cancer Research UnitedOTHER | 1 | Jan 18, 2020 | clinicaltrials |
| NCT00388726 | E7389 Versus Treatment of Physician's Choice in Patients With Locally Recurrent or Metastatic Breast Cancer | completed | Phase 3 | 762 | Eisai Inc.INDUSTRY | 17 | Jan 7, 2020 | clinicaltrials |
| NCT00068601 |
| S0230 Goserelin in Preventing Ovarian Failure in Women Receiving Chemotherapy for Breast Cancer |
| completed |
| Phase 3 |
| 257 |
| SWOG Cancer Research NetworkNETWORK |
| 6 |
| Dec 30, 2019 |
| clinicaltrials |
| NCT00600340 | 2-arm Trial of Paclitaxel Plus Bevacizumab vs. Capecitabine Plus Bevacizumab(TURANDOT) | completed | Phase 3 | 564 | Central European Cooperative Oncology GroupOTHER | 12 | Dec 30, 2019 | clinicaltrials |
| NCT00390455 | Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive | completed | Phase 3 | 295 | National Cancer Institute (NCI)NIH | 1 | Dec 20, 2019 | clinicaltrials |
| NCT00567190 | A Study to Evaluate Pertuzumab + Trastuzumab + Docetaxel vs. Placebo + Trastuzumab + Docetaxel in Previously Untreated HER2-Positive Metastatic Breast Cancer(CLEOPATRA) | completed | Phase 3 | 808 | Genentech, Inc.INDUSTRY | 26 | Dec 13, 2019 | clinicaltrials |
| NCT00001806 | Methods in Education for Breast Cancer Genetics | completed | Phase 3 | 170 | National Cancer Institute (NCI)NIH | 1 | Dec 12, 2019 | clinicaltrials |
| NCT00536081 | Various G-CSF Regimens to Prevent Infection During Chemotherapy | completed | Phase 3 | 172 | Academisch Ziekenhuis MaastrichtOTHER | 1 | Nov 6, 2019 | clinicaltrials |
| NCT00393172 | Women in Steady Exercise Research [Formerly Women, Oxidative Stress, Exercise and Estrogens (WOSEE)](WISER) | completed | Phase 2 / Phase 3 | 400 | University of MinnesotaOTHER | 1 | Nov 1, 2019 | clinicaltrials |
| NCT02126449 | DIetary REstriction as an Adjunct to Neoadjuvant ChemoTherapy for HER2 Negative Breast Cancer(DIRECT) | completed | Phase 2 / Phase 3 | 131 | Leiden University Medical CenterOTHER | 1 | Oct 24, 2019 | clinicaltrials |
| NCT01104935 | National Surgical Adjuvant Study of Breast Cancer(N-SAS BC) 07 [RESPECT](RESPECT) | completed | Phase 3 | 275 | Comprehensive Support Project for Oncology ResearchOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT02376985 | Evaluation of Oral Care to Prevent Oral Mucositis in ER Positive MBC Patients Treated With Everolimus: Phase 3 RCT | completed | Phase 3 | 174 | Comprehensive Support Project for Oncology ResearchOTHER | 1 | Oct 21, 2019 | clinicaltrials |
| NCT01591746 | Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction | completed | Phase 3 | 131 | Mayo ClinicOTHER | 1 | Oct 10, 2019 | clinicaltrials |
| NCT01856543 | Mometasone Furoate 0.1% Versus Eucerin on Moderate to Severe Skin Toxicities in Breast Cancer Patients Receiving Postmastectomy Radiation | completed | Phase 3 | 143 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT02115204 | 4 x Epirubicin, Cyclophosphamide, Followed by 4 x Docetaxel Versus 6 x CMF / 6 x CEF | completed | Phase 3 | 2,011 | Women's Cancer Study Group GmbHOTHER | 1 | Oct 3, 2019 | clinicaltrials |
| NCT00295620 | Secondary Adjuvant Long Term Study With Arimidex(SALSA) | completed | Phase 3 | 3,484 | AstraZenecaINDUSTRY | 1 | Oct 2, 2019 | clinicaltrials |
| NCT01926886 | A Study of Subcutaneous At Home Administration of Trastuzumab (Herceptin) in Participants With Human Epidermal Growth Factor Receptor 2-positive (HER2+) Early Breast Cancer (eBC) | completed | Phase 3 | 102 | Hoffmann-La RocheINDUSTRY | 2 | Sep 18, 2019 | clinicaltrials |
| NCT01091168 | Trial of Vinflunine Versus Alkylating Agent in Metastatic Breast Cancer | completed | Phase 3 | 594 | Pierre Fabre MedicamentINDUSTRY | 14 | Sep 16, 2019 | clinicaltrials |
| NCT02402712 | Phase IIIb Study to Evaluate the Safety and Tolerability of Herceptin SC With Perjeta and Docetaxel in Patients With HER2-positive Advanced Breast Cancer | completed | Phase 3 | 418 | Hoffmann-La RocheINDUSTRY | 12 | Sep 6, 2019 | clinicaltrials |
| NCT02040935 | A Study of SC Administration of Trastuzumab (Herceptin) by SID at Home in HER2-Positive EBC Participants(HOMERUS) | completed | Phase 3 | 128 | Hoffmann-La RocheINDUSTRY | 1 | Aug 22, 2019 | clinicaltrials |
| NCT01901146 | Efficacy and Safety Study of ABP 980 Compared With Trastuzumab in Women With HER2-positive Early Breast Cancer(Lilac) | completed | Phase 3 | 725 | AmgenINDUSTRY | 18 | Aug 7, 2019 | clinicaltrials |
| NCT01644890 | A Phase III Study of NK105 in Patients With Breast Cancer | completed | Phase 3 | 436 | Nippon Kayaku Co., Ltd.INDUSTRY | 1 | Jul 29, 2019 | clinicaltrials |
| NCT01125566 | LUX-Breast 1: BIBW 2992 (Afatinib) in HER2-positive Metastatic Breast Cancer Patients After One Prior Herceptin Treatment | completed | Phase 3 | 508 | Boehringer IngelheimINDUSTRY | 38 | Jul 18, 2019 | clinicaltrials |
| NCT02408393 | MIRs03: Paravertebral Block With Ropivacaine Before Breast Cancer Surgery(MIRs03) | completed | Phase 3 | 380 | Institut CurieOTHER | 1 | Jul 10, 2019 | clinicaltrials |
| NCT02995772 | Neoadjuvant Hormonal Therapy Compared to Neoadjuvant Chemotherapy in Stage IIIB/C and IV Breast Cancer Patients | completed | Phase 3 | 122 | Dharmais National Cancer Center HospitalOTHER_GOV | 1 | Jun 19, 2019 | clinicaltrials |
| NCT01645839 | Interest of Intrathecal Chemotherapy With Liposomal Cytarabine (DepoCyte®) in Meningeal Metastasis of Breast Cancer(DEPOSEIN) | completed | Phase 3 | 74 | Centre Oscar LambretOTHER | 1 | Jun 12, 2019 | clinicaltrials |
| NCT00144898 | GF-GS 01: Comparing Conventional Axillary Dissection Versus Sentinel Node Resection in Clinically Node-negative Operable Breast Cancer | completed | Phase 3 | 1,627 | Hospices Civils de LyonOTHER | 1 | May 28, 2019 | clinicaltrials |
| NCT00992706 | F511 Cream in Preventing Palmar-Plantar Erythrodysesthesia in Patients Receiving Doxorubicin Hydrochloride Liposome for Metastatic Breast Cancer | completed | Phase 3 | 91 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT01131195 | Metronomic Therapy in Metastatic Breast Cancer. | completed | Phase 3 | 139 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT02311543 | Impact of a Surgical Sealing Patch on Lymphatic Drainage After ALND for Breast Cancer | completed | Phase 3 | 142 | Swiss Cancer InstituteOTHER | 1 | May 15, 2019 | clinicaltrials |
| NCT00776724 | Tailored Neoadjuvant Chemotherapy for Stage II/III Breast Cancer With Tumor Size More Than 2 cm(TaiNAC) | completed | Phase 3 | 166 | National Taiwan University HospitalOTHER | 1 | May 6, 2019 | clinicaltrials |
| NCT01953003 | Phase III Study of Vinflunine Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast Cancer | completed | Phase 3 | 112 | Pierre Fabre MedicamentINDUSTRY | 3 | May 2, 2019 | clinicaltrials |
| NCT02253459 | Clinical Study of UTD1 Injection in Combination With Capecitabine in Patients With Advanced and Metastatic Breast Cancer | completed | Phase 3 | 405 | Beijing Biostar Pharmaceuticals Co., Ltd.INDUSTRY | 1 | Apr 9, 2019 | clinicaltrials |
| NCT03888677 | Dose-adjusted Adjuvant FEC Compared to Standard FEC for Breast Cancer | completed | Phase 3 | 1,535 | Henrik LindmanOTHER | 0 | Mar 28, 2019 | clinicaltrials |
| NCT00418028 | Standard Versus Continuous Capecitabine in Advanced Breast Cancer | completed | Phase 2 / Phase 3 | 195 | Hospital San Carlos, MadridOTHER | 1 | Feb 22, 2019 | clinicaltrials |
| NCT01881230 | Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)(tnAcity) | completed | Phase 2 / Phase 3 | 191 | CelgeneINDUSTRY | 12 | Feb 21, 2019 | clinicaltrials |
| NCT01376349 | Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms | completed | Phase 3 | 464 | Alliance for Clinical Trials in OncologyOTHER | 1 | Feb 7, 2019 | clinicaltrials |
| NCT03240224 | Bioinformation Therapy for Breast Cancer | completed | Phase 2 / Phase 3 | 120 | Fuda Cancer Hospital, GuangzhouOTHER | 1 | Jan 25, 2019 | clinicaltrials |
| NCT00513292 | Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery | completed | Phase 3 | 280 | National Cancer Institute (NCI)NIH | 2 | Jan 23, 2019 | clinicaltrials |
| NCT02187744 | A Study Of PF-05280014 Or Trastuzumab Plus Taxotere® And Carboplatin In HER2 Positive Breast Cancer In The Neoadjuvant Setting (REFLECTIONS B327-04) | completed | Phase 3 | 226 | PfizerINDUSTRY | 10 | Jan 8, 2019 | clinicaltrials |
| NCT00876395 | Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer(BOLERO-1) | completed | Phase 3 | 719 | Novartis PharmaceuticalsINDUSTRY | 28 | Dec 19, 2018 | clinicaltrials |
| NCT01073865 | Study to Compare Zoladex™ 10.8 mg With Zoladex 3.6 mg in Pre-menopausal Women With Breast Cancer | completed | Phase 3 | 222 | AstraZenecaINDUSTRY | 6 | Dec 12, 2018 | clinicaltrials |
| NCT01764022 | A Safety and Efficacy Study of BCD-022 With Paclitaxel Compared to Herceptin With Paclitaxel in HER2+ Metastatic Breast Cancer Patients | completed | Phase 3 | 225 | BiocadINDUSTRY | 4 | Nov 29, 2018 | clinicaltrials |
| NCT00046865 | Acupressure in Treating Nausea in Women Receiving Combination Chemotherapy for Breast Cancer | completed | Phase 3 | 57 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 14, 2018 | clinicaltrials |
| NCT00869206 | Zoledronic Acid in Treating Patients With Metastatic Breast Cancer, Metastatic Prostate Cancer, or Multiple Myeloma With Bone Involvement | completed | Phase 3 | 1,822 | Alliance for Clinical Trials in OncologyOTHER | 2 | Nov 7, 2018 | clinicaltrials |
| NCT00002836 | Filgrastim Plus Chemotherapy Compared With Filgrastim Alone In Treating Women Undergoing Peripheral Stem Cell Transplantation For Breast Cancer | completed | Phase 3 | 184 | M.D. Anderson Cancer CenterOTHER | 1 | Nov 6, 2018 | clinicaltrials |
Data updated 23 days agoSource updated Jan 18, 2020source: clinicaltrials